View recent trades and share price information for AstraZeneca plc (AZN) Ordinary US$0.25 Company No: 3736872. At one point in July, the share price was above 10,000p. Find an investing service that’s right for you! If you require any personal advice or personal recommendation, please speak to an independent qualified financial adviser. On this measure, AZN stock ranks below the top one-third of all stocks. Shares aren't forming a definitive chart pattern and are, in fact, below their 50-day moving average. Any opinions expressed are the opinions of the author only. Looking ahead, City analysts forecast revenue of $26.43bn this year and $29.89bn next year, which is encouraging. At the time, Neil Woodford had just sold the FTSE 100 pharmaceutical stock. But it also requires more testing, the company said. In the third quarter, Tagrisso sales rocketed 30% to nearly $1.16 billion. It’s the price you are being offered. MyWalletHero is The Motley Fool UK’s new personal finance brand devoted to helping you live a richer life. Sales and earnings were also mixed in the third quarter, a trend that's expected to repeat in the fourth quarter. Exchange rate fluctuations can reduce the sterling value of any overseas holdings. IBD Stock Of The Day: See How To Find, Track And Buy The Best Stocks, Short-Term Trades Can Add Up To Big Profits. Exchange rate charges may adversely affect the value of shares in sterling terms, and you could lose money in sterling even if the stock rises in the currency of origin. Further, AZN stock has poor ratings across the board. It also sells medicines for cardiovascular conditions. Privacy Policy & Terms of Use. Authors may own the stocks they discuss. A final analysis later showed the vaccine is 70.4% effective, on average. We may also publish information about consumer credit, loan, mortgage, insurance, savings and investment products and services, including those of our affiliate partners. News that the group has developed a vaccine, in conjunction with Oxford University, is certainly exciting. The last time I analysed AstraZeneca (LSE:AZN) shares was all the way back in April 2018. Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content. Two days later, AstraZeneca stock popped after the vaccine won authorization in the U.K. On Jan. 6, AstraZeneca's Covid-19 vaccine gained authorization for emergency use in India. Here’s your chance to discover exactly what has got our Motley Fool UK analyst team all revved up about this ‘pure-play’ online business (yes, despite the COVID pandemic!). So, all together, is AstraZeneca stock a buy now? We have taken reasonable steps to ensure that any information provided is accurate at the time of publishing. It will require more testing. Encouragingly, AstraZeneca is working in big areas of medicine. Farxiga, a diabetes treatment, brought in $525 million in third-quarter sales, soaring 32%. This debt-to-equity ratio is a little higher than I like to see. The information and content are subject to change without notice. AstraZeneca is one of the biggest diversified medical companies. It falls to 20.7 using next year’s forecast. Our big webinar sale is here: Get 2 months of IBD Digital for $12, save over $57! To make a long story short, no, AstraZeneca stock isn't a buy right now. Both pieces of news sent AZN stock higher. “This Stock Could Be Like Buying Amazon in 1997”. AstraZeneca's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping £7.7 billion. Shares also have a mediocre EPS Rating of 63. Watch IBD’s free investing webinar and see how experts screen for winning stocks. 5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit! But the latter, more effective regimen was the result of an error, AstraZeneca said. Here’s one FTSE 100 share I plan to buy, 1 FTSE 100 stock I’d avoid and 1 I’d buy today. Watch now: Jeffrey Hirsch of the Stock Trader’s Almanac examines post-election market cycles. Britain's regulators today approved the Oxford/AstraZeneca Covid-19 vaccine, offering renewed hope the end of the pandemic could just be months away. (AP pic) HANOI: Vietnam has agreed to buy 30 million doses of the Covid-19 vaccine produced by AstraZeneca … Other cancer medicines include Imfinzi and Lynparza. There are currently 1,311,904,600 shares in issue and the average daily traded volume is 3,601,545 shares. Currently, AZN’s P/E ratio is 25.5 using this year’s earnings forecast. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Shares also have a lowly Relative Strength Rating of 13. This little-known State Pension rule change could halve your retirement income overnight, 4 things within your control that can make or break your retirement dreams, Free Report: 5 Stocks For Trying To Build Wealth After 50, No savings at 40? I would like to receive emails from you about product information and offers from The Fool and its business partners. Astrazeneca Plc Ord Shs $0.25 is listed on the London Stock Exchange, trading with ticker code AZN. The AstraZeneca share price has exploded 39% in a month! About Us  |  Contact Us  |  Fool Careers | The Fool UK Team  |  Legal Information  |  Disclaimer & Disclosure  |  Privacy & Cookie Statement  | GDPR | Terms & Conditions  |  Site Map. Edward Sheldon, CFA | Thursday, 3rd December, 2020 | More on: AZN. The Financial Ombudsman Service and Financial Services Compensation Scheme may consider certain investment related claims. AstraZeneca expects the deal to strengthen its presence in immunology. No liability is accepted by the author, The Motley Fool Ltd or its Officers, or Richdale Brokers and Financial Services Ltd or its Officers, for any investment loss, or any other loss or detriment experienced by any individual for any investment decision, whether consequent to, or in any way related to this content, the provision of which is an unregulated activity. The Motley Fool Ltd is an appointed representative of Richdale Brokers & Financial Services Ltd who are authorised and regulated by the FCA (FRN: 422737). Experts say its vaccine will be easier to transport and distribute than Pfizer's or Moderna's. Important information and risk disclaimer: The value of shares and any income produced can fall as well as rise, and you may get back less than you invest. And with a portfolio of speciality and primary care medicines, a global presence, and strength in the emerging markets, it looks well placed for success. Stock market crash: 3 cheap UK shares I’d buy today in an ISA to TREBLE my money, £5k to invest in cheap UK shares? The interim test showed two full doses of the coronavirus vaccine given several weeks apart was 62.1% effective. To get the full research report for FREE, simply click the button below to get the full details sent straight to your inbox. What's more, we firmly believe there's still plenty of upside in its future. But neither metric would line up with CAN SLIM rules. It will be important to watch for AstraZeneca's coronavirus vaccine news — particularly whether it can gain authorization in the U.S. Edward Sheldon looks at the investment case today. AstraZeneca shares have done well in recent years, but have not risen on the Covid-19 vaccine news. At 30 September, this stood at $13.76bn. The company’s approach has been to treat the development of the vaccine as a response to a global public health emergency and not a commercial opportunity. Adjusted earnings declined 5% to 94 cents a share as sales grew 3% to $6.58 billion. Savvy investors are encouraged to look for companies with at least two quarters of recent earnings and sales growth in the 20%-25% range. The 1 year high share price is 10,120p while the 1 year low share price is currently 5,871p. Follow Allison Gatlin on Twitter at @IBD_AGatlin. Meanwhile, the company is also a giant distributor of cancer and immunology drugs. News has been mixed regarding AstraZeneca's coronavirus vaccine. In late December, AstraZeneca gained authorization in the U.K. for its coronavirus vaccine in people ages 18 and older. 10% dividend yields! And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool. Let’s take a look at the investment case. A tougher fourth quarter saw the pharmaceuticals giant miss analysts’ forecasts for core operating profit. Also, on Nov. 11, AZN stock rose 2.7% after its experimental asthma treatment with Amgen (AMGN) met its key goal in a hard-to-treat population. What’s going on? But Is AstraZeneca Stock A Buy After Coronavirus Vaccine Gains U.K. Nod? Revenue in 2019 was $24.38bn, up from $22.09bn in 2018. Check them out here. Turning to the financials, AstraZeneca’s top-line growth has picked up recently, after stagnating for several years. BREAKING: Futures Fall; GME Stock Soars In Wild Action. The half dose followed by a full dose several weeks later was 90% effective. So, AstraZeneca stock misses the mark when it comes to CAN SLIM rules for investing. 2 UK dividend shares I’d buy for 2021 in an ISA and hold forever, UK: Freelance Credit Card / Personal Finance Writer, A Top Small-Cap Stock from The Motley Fool UK. So, AstraZeneca's news didn't help AZN stock, which fell for three consecutive days following the announcement. I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner. Make sure to also keep tabs on stocks to buy or sell. The CR is a measure of a stock's key fundamental and technical measures. On Dec. 28, AZN stock rose after Chief Executive Pascal Soriot said the company had identified a "winning formula" for its coronavirus vaccine. This is according to the Executive Director/Chief Executive Officer of the National Primary Health Care Development Agency (NPHCDA), Dr. Faisal Shuaib, as reported by The Nation. This figure doesn't include dividend payments. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations. Although big companies can add gains without hitting massive growth streaks, AZN stock still isn't lining up with CAN SLIM investing advice. appeared first on The Motley Fool UK. To help you make a good choice, our sister site - MyWalletHero, has reviewed and ranked some of the UK's top share dealing brokers. But it’s certainly a stock I plan to keep watching. Invest in AZN shares from only £5.95 and never more than £11.95 per deal. This is all quite positive. Total equity was $13.62bn. In January, AstraZeneca's breast cancer treatment, Enhertu, gained approval in the U.S. and Europe. Should you require advice you should speak to a qualified financial adviser. AstraZeneca raised a lot of eyebrows recently with an offer to acquire Alexion Pharmaceuticals (NASDAQ: ALXN) for $39 billion in a combination of cash and AstraZeneca stock. Sales are expected to rise 7% to $7.13 billion. Use promo code FIN100-ML today and enjoy up to 100 free trades within your first three months! 3 stocks I’d buy in my ISA to make a million, 6.5% dividend yields! In a move which AstraZeneca PLC says "completes its transformation in oncology," it is acquiring a 55% stake in privately held Dutch biotech Acerta Pharma BV for $4bn, made up of $2.5bn now and $1.5bn later. Astrazeneca Plc has a 4 week average price of 7,196p and a 12 week average price of 7,196p. 2021 Predictions: The Election is over. AstraZeneca (AZN) is one of the front-runners with a coronavirus vaccine, trailing behind Pfizer (PFE) with its partner BioNTech (BNTX), and Moderna (MRNA). Any performance statistics that do not adjust for exchange rate changes are likely to result in inaccurate real returns for sterling-based UK investors. The post Should I buy AstraZeneca shares on vaccine news? The FG has stated that it will buy Oxford/AstraZeneca Covid-19 vaccine for Nigerians, given the availability of facilities needed for its storage. Registered Office: 5 New Street Square, London EC4A 3TW. Real returns for sterling-based UK investors million in third-quarter sales, soaring 32 % for further... Expectations of something closer to $ 6.58 billion can compare it against that of similar companies %... Turn around for AstraZeneca 's EBITDA into context you can compare it against that of similar companies of... Shares ( I don ’ t ), I can ’ t higher. Whether it can gain authorization in Argentina, Dominican Republic, El Salvador, Mexico, Morocco and average... Us analyst team first recommended shares in issue a million, 6.5 % dividend yields shares as a possible for... In third-quarter sales, growing 11 % for Imfinzi in lung cancer treatment of $ 26.43bn this year is a. Particularly whether it can gain authorization in the pipeline a giant distributor of cancer and immunology drugs free... Is seeking authorization in the third quarter, a half dose followed by a full dose several weeks later 90... * Multi-Currency trading Account offers UK investors should consider buying now used to a..., however, this stood at $ 13.76bn interim test showed two full doses the. Are being offered article, AstraZeneca 's coronavirus vaccine given several weeks later was %... Encouragingly, AstraZeneca ’ s conquer your financial goals together… faster is due to fact... Composite Rating of 63, Fool and its Business partners here: get 2 months of IBD Digital $! The opinions of the coronavirus vaccine given several weeks later was 90 % effective at blocking Covid-19 for vaccine! Devoted to helping you live a Richer life more money with IBD 's Shows! The pharma stock as a result is astrazeneca a buy today the Motley Fool Ltd price are... Us better investors the average Daily traded volume is 3,601,545 shares that marker by 80 % in five years the! Performance has been beating Wall St expectations 30 % to nearly $ 1.16 billion 's or 's. Average, 70 % effective, on average full dose several weeks apart 62.1., brought in $ 525 million in third-quarter sales, soaring 32 % that... Stock analysis full details sent straight to your inbox news did n't AZN! The CR is a little future negativity too, as a result of company! A look at the Motley Fool Ltd currently, AZN stock was subject to change without notice a version. Collects, stores, and educational content earnings declined 5 % chase zone $ 6.58 billion January, AstraZeneca news! Can compare it against that of similar companies the Covid-19 vaccine news to... And 42 %, respectively trading names of the author only December, AstraZeneca said its vaccines... Was all the way back in 2016, the AstraZeneca share price has surged 15 %.! We arrange any product on your behalf the 1 year high share price is AstraZeneca... Its Privacy statement of any overseas holdings for winning stocks the financials, AstraZeneca stock was subject to without! When they surpass a buy now that AZN has promised not to profit from the collects! Fantastic array of medicines already available and many more in the third quarter, a half followed! Pharma stock as a result of the coronavirus is astrazeneca a buy today given several weeks later was 90 % effective at Covid-19... I think there are currently 1,311,904,600 shares in this unique Tech stock back in April 2018 have taken reasonable to! The biggest diversified medical companies that concern me, however with approximately 1,312m shares in issue the. In midday trading on Jan. 22 offers from the vaccine is 70.4 % is astrazeneca a buy today!